{"id":"9eaab018-95d1-468a-8672-94029ac04f8d","kind":"institutions","code":"UB-I1579","name":"Regeneron Ventures","nameBasis":"original-brand","summary":"Regeneron's strategic investment division, focused on life sciences and gene editing.","description":"Regeneron's strategic investment division, focused on life sciences and gene editing.","country":null,"category":null,"originalName":"Regeneron Ventures","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T11:04:21.051Z","englishUpdatedAt":"2026-10-15T21:39:21.220Z","reviewedAt":"2026-10-15T21:39:21.220Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"d202f27a98aa9e80fc6d2caaa70089a5feb4c8781fdf86590600ee0222029f76","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"再生元制药（Regeneron）旗下战略投资部门，聚焦生命科学与基因编辑。","sources":[],"related":[{"id":"53d76ce4-822b-4768-87b6-7a71de6c3e37","kind":"news","code":"53d76ce4-822b-4768-87b6-7a71de6c3e37","name":"Iambic Therapeutics raises USD 100 million in equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"Iambic Therapeutics完成1亿美元股权投资融资","eventDate":"2025-11-10T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-15T17:08:08.128Z","englishUpdatedAt":"2026-10-15T18:35:35.829Z","reviewedAt":"2026-10-15T18:35:35.829Z","snapshotAt":"2026-10-15T18:31:34.288Z","sourceHash":"32a6c5b93f3984ed14ac3b7fb7b820e0ce00d1757be85b393e7ec2c4726514b7","companyId":"217c9186-2e9b-4e07-b192-25de64a27b49","foundedYear":null,"logoUrl":null,"path":"/news/53d76ce4-822b-4768-87b6-7a71de6c3e37"}],"path":"/institutions/regeneron-ventures","structured":{"city":null,"country":"United States","location":null,"role":null,"category":null,"company":null},"definition":"Regeneron Ventures is a corporate venture capital investor based in the United States with 1 recorded investment.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/regeneron-ventures"}